Is angiotensin-converting enzyme inhibitor and angiotensin receptor blocker combination therapy better than monotherapy and safe in patients with CKD?
Berns
Jeffrey S
JS
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. bernsj@uphs.upenn.edu